List view / Grid view

Dr Dominic E. Adair

 

Biosimilars: litigation outlook

20 October 2016 | By

In the Foreword article contributed by Consultant David P. Elder in Issue 3, 2016 of European Pharmaceutical Review, entitled ‘Biosimilars: future prospects’, Dr Elder concluded that it is likely that biosimilars will become increasingly established in both Europe and the United States and that in addition to proteins and peptides,…

Send this to a friend